Goldman Sachs
RAIN

Goldman Sachs’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Goldman Sachs’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28,434
Closed -$24.5K – 5910
2023
Q3 		$24.5K Sell
28,434
-210,182
-88% -$230K ﹤0.01% 5338
2023
Q2 		$286K Buy
238,616
+153,534
+180% +$768K ﹤0.01% 5035
2023
Q1 		$744K Buy
+85,082
New +$787K ﹤0.01% 4598
2022
Q3 		– Sell
-10,072
Closed -$56K – 6660
2022
Q2 		$56K Sell
10,072
-6,583
-40% -$22.6K ﹤0.01% 6009
2022
Q1 		$84K Buy
16,655
+6,617
+66% +$53.1K ﹤0.01% 6160
2021
Q4 		$129K Buy
+10,038
New +$143K ﹤0.01% 6062

Other funds holding RAIN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's RAIN Position: Q4 2023 in Review

Goldman Sachs sold out of Rain Oncology Inc. Common Stock (RAIN) in Q4 2023, closing a stake of 28,434 shares — an estimated $24.5K sold.

Goldman Sachs first reported a position in RAIN in Q4 2021 and held it in 6 quarters. The position peaked at $744K in Q1 2023. 58 funds tracked by Wall St. Rank hold RAIN as of Q4 2023.

  • Goldman Sachs reported no remaining Rain Oncology Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Goldman Sachs sold 28,434 Rain Oncology Inc. Common Stock shares in Q4 2023, an estimated $24.5K.
  • Goldman Sachs first reported a position in Rain Oncology Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Goldman Sachs's Rain Oncology Inc. Common Stock position peaked at $744K in Q1 2023.
  • 58 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q4 2023.

Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.